Tumores Neuroendocrinos: Un desafío transversal

DIEGO CARRILLO, MATÍAS MUÑOZ-MEDEL, IGNACIO RETAMAL, MAURICIO PINTO, MARÍA L. BRAVO, BRUNO NERVI, JOSÉ PEÑA, YASNA VALENZUELA, FRANCISCO J. GUARDA, FLAVIA NILO, FERNANDO BELLO, PILAR ORELLANA, DANIEL VICENTINI, JUAN CARLOS QUINTANA, PAULA J. TORRES, JOSÉ LUIS LEAL, MARCELO GARRIDO*

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

Resumen

Neuroendocrine Tumors (NETs) encompass a wide variety of tumors arising from neuroendocrine cells, which produce bioactive substances. The incidence of NETs increased significantly lately, becoming one of the most common tumors of the digestive tract. Their clinical presentation is as diverse as their capacity for hormone production. Carcinoid syndrome is the most common hormonal syndrome produced by NETs and is characterized by diarrhea, flushing and cardiac valvular lesions. New research brought multiple changes in the classification of these neoplasms and a new understanding about their diagnosis and treatment, promoting a multidisciplinary approach. Somatostatin analogues, radiation, biological, and cytotoxic drugs have improved the prognosis of these patients, which entails a great challenge for healthcare providers.

Título traducido de la contribuciónUpdate on neuroendocrine tumors
Idioma originalEspañol
Páginas (desde-hasta)888-898
Número de páginas11
PublicaciónRevista Medica de Chile
Volumen149
N.º6
DOI
EstadoPublicada - jun. 2021
Publicado de forma externa

Nota bibliográfica

Publisher Copyright:
© 2021 Sociedad Medica de Santiago. All rights reserved.

Palabras clave

  • Biomarkers, Tumor
  • Malignant Carcinoid Syndrome
  • Neuroendocrine Tumors
  • Somatostatin

Huella

Profundice en los temas de investigación de 'Tumores Neuroendocrinos: Un desafío transversal'. En conjunto forman una huella única.

Citar esto